Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elfrida R Benjamin

Co-Administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human Α-Galactosidase a Tissue Uptake and Improves Substrate Reduction in Fabry Mice

Molecular Therapy

English

Reduction of Podocyte Globotriaosylceramide Content in Adult Male Patients With Fabry Disease With Amenable GLA Mutations Following 6 Months of Migalastat Treatment

Journal of Medical Genetics

Genetics

2017

English

Related publications

Fabry Disease: Effective Tissue Substrate Depletion Following Enzyme Replacement in Α-Galactosidase a Deficient Mice. • 607

English

Distribution of -Galactosidase a in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant -Galactosidase a in Fabry Mice

Journal of the American Society of Nephrology : JASN

Medicine

Nephrology

2007

English

Receptor-Mediated Endocytosis of Α-Galactosidase a in Human Podocytes in Fabry Disease

PLoS ONE

Multidisciplinary

2011

English

Adipocytes Participate in Storage in Α-Galactosidase Deficiency (Fabry Disease)

Journal of Inherited Metabolic Disease

Genetics

2010

English

Prediction of Response of Mutated Alpha-Galactosidase a to a Pharmacological Chaperone

Pharmacogenetics and Genomics

English

Fabry Disease: Twenty Novel Α-Galactosidase a Mutations Causing the Classical Phenotype

Journal of Human Genetics

Genetics

2001

English

Impact of Cysteine Variants on the Structure, Activity, and Stability of Recombinant Human Α-Galactosidase A

English

Strong Increase of Leukocyte Apha‐galactosidase a Activity in Two Male Patients With Fabry Disease Following Oral Chaperone Therapy

Molecular genetics & genomic medicine

Genetics

Molecular Biology

2019

English

Monoclonal Antibody Po66 Uptake by Human Lung Tumours Implanted in Nude Mice: Effect of Co-Administration With Doxorubicin

British Journal of Cancer

Cancer Research

Oncology

1995

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elfrida R Benjamin

Co-Administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human Α-Galactosidase a Tissue Uptake and Improves Substrate Reduction in Fabry Mice

Reduction of Podocyte Globotriaosylceramide Content in Adult Male Patients With Fabry Disease With Amenable GLA Mutations Following 6 Months of Migalastat Treatment

Related publications

Fabry Disease: Effective Tissue Substrate Depletion Following Enzyme Replacement in Α-Galactosidase a Deficient Mice. • 607

Distribution of -Galactosidase a in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant -Galactosidase a in Fabry Mice

Receptor-Mediated Endocytosis of Α-Galactosidase a in Human Podocytes in Fabry Disease

Adipocytes Participate in Storage in Α-Galactosidase Deficiency (Fabry Disease)

Prediction of Response of Mutated Alpha-Galactosidase a to a Pharmacological Chaperone

Fabry Disease: Twenty Novel Α-Galactosidase a Mutations Causing the Classical Phenotype

Impact of Cysteine Variants on the Structure, Activity, and Stability of Recombinant Human Α-Galactosidase A

Strong Increase of Leukocyte Apha‐galactosidase a Activity in Two Male Patients With Fabry Disease Following Oral Chaperone Therapy

Monoclonal Antibody Po66 Uptake by Human Lung Tumours Implanted in Nude Mice: Effect of Co-Administration With Doxorubicin